Overview

Treatment of Post-SCI Hypotension

Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
While treatment strategies for OH have been identified for use in persons with acute SCI, the field of SCI medicine lacks a gold standard for treatment thresholds and well-defined outcome parameters. Comprehensively documenting the impact of orthostatic hypotension (OH), regardless of symptoms, during acute rehabilitation and identifying the effects of two different treatment approaches on therapy participation and adherence to an intended rehabilitation plan could have a significant impact on clinical practice in the acute rehabilitation setting following SCI.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
James J. Peters Veterans Affairs Medical Center
Collaborator:
Icahn School of Medicine at Mount Sinai
Treatments:
Midodrine